Sarfez Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsSarfez Pharmaceuticals

Sarfez Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Soaanz	Torsemide	2021-06-14	2033	Heart failure , Hypertension , Chronic kidney failure , Liver cirrhosis , Nephrotic syndrome , Edema , Ascites , Pulmonary edema

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

food-drug interactions

,

body weight changes

,

overactive urinary bladder

,

urinary incontinence

,

healthy volunteers/patients

,

,

,

chronic renal insufficiency

,

,

,

,

,

myeloid leukemia acute

,

deficiency diseases

,

paraproteinemias

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

breast neoplasms

,

immune system diseases

,

hematologic neoplasms

,

type 2 diabetes mellitus

,

,

metabolic diseases

,

,

glycogen storage disease

,

,

immunoglobulin g4-related disease

,

,

myeloid leukemia

,

,

falciparum malaria

,

,

,

,

,

polycystic kidney diseases

,

autosomal dominant polycystic kidney

,

,

,

renal insufficiency

,

hematologic diseases

,

blood protein disorders

,

neoplasms by histologic type

,

prostatic neoplasms

,

circulating neoplastic cells

,

x-linked bulbo-spinal atrophy

,

heart transplantation

,

non-small-cell lung carcinoma

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

esophageal neoplasms

,

,

neoplasm metastasis

,

aplastic anemia

,

multiple myeloma

,

hypercholesterolemia

,

meningococcal infections

,

plasma cell neoplasms

,

hemolytic anemia autoimmune

,

,

meningococcal meningitis

,

stomach neoplasms

,

,

kidney diseases

,

gaucher disease

,

,

chronic renal insufficiency

,

hyperphosphatemia

,

multiple sclerosis

,

,

homozygous familial hypercholesterolemia

,

hyperlipoproteinemia type ii

,

,

,

healthy volunteers/patients

,

,

glycogen storage disease type ii

,

atopic dermatitis

,

diabetes mellitus

,

insulin resistance

,

,

glycogen storage disease type iii

,

,

non-hodgkin lymphoma

,

,

postmenopausal osteoporosis

,

,

lymphoproliferative disorders

,

left ventricular dysfunction

,

ventricular dysfunction

,

Histone-arginine methyltransferase carm1

squamous cell carcinoma of head and neck

,

healthy volunteers/patients

,

squamous cell carcinoma

,

triple negative breast neoplasms

,

,

head and neck neoplasms

,

,

colorectal neoplasms

,

,

parkinson disease

,

myeloid leukemia acute

,

squamous cell neoplasms

,

,

large b-cell lymphoma diffuse

,

b-cell chronic lymphocytic leukemia

,

non-hodgkin lymphoma

,

acute kidney injury

,

follicular lymphoma

,

liver cirrhosis

,

,

,

chronic hepatitis c

,

,

vascular surgical procedures

,

wounds and injuries

,

,

hairy cell leukemia

,

b-cell lymphoma marginal zone

,

pancreatic neoplasms

,

neoplasm metastasis

,

,

urologic neoplasms

,

transitional cell carcinoma

,

,

non-small-cell lung carcinoma

,

multiple myeloma

,

liver neoplasms

,

myelodysplastic syndromes

,

plasma cell neoplasms

,

ovarian neoplasms

,

hepatocellular carcinoma

,

takayasu arteritis

,

fallopian tube neoplasms

,

peritoneal neoplasms

,

mucopolysaccharidoses

,

mucopolysaccharidosis i

postoperative nausea and vomiting

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use